GlucoTrack - נכסים נקיים למניה בודדת GCTK

Organized mail delivery of devices simplifies patient access to therapy, yet the lack of current profits and reliance on legacy investments create a financial gap. The net book value per share on the GURU.Markets portal is illustrated in this chart, where the metric settled at -8.37, revealing the actual capital. The success of GlucoTrack, Inc. (GCTK) now hinges on the accuracy of non-invasive sensors and FDA approval.

Investments in a staff of highly qualified biomedical engineers to develop glucose monitoring systems directly form the tangible basis of GlucoTrack, Inc. This metric is calculated as the difference between total assets and liabilities divided by the number of shares; by analyzing the book value per share, an investor determines the actual value of the equity stake, which allows for the minimization of risks during market volatility.